Study to Evaluate Efficacy and Safety of Oral Abexinostat in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

RECRUITING

China-Japan Friendship Hospital, Beijing

RECRUITING

Peking University Third Hospital, Beijing

RECRUITING

The First Affiliate Hospital of Dalian Medical University, Dalian

RECRUITING

The Affiliated Tumor Hospital of Harbin Medical University, Harbin

RECRUITING

Shanghai Jiao Tong University School Medicine, Shanghai

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

RECRUITING

The Affiliated Hospital of Xuzhou Medical University, Xuzhou

RECRUITING

Nantong Tumor Hospital, Nantong

RECRUITING

Linyi Cancer Hospital, Linyi

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

RECRUITING

Fujian Medical University Union Hospital, Fuzhou

RECRUITING

Fujian Provincial Cancer Hospital, Fuzhou

RECRUITING

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

RECRUITING

Henan Cancer Hospital, Zhengzhou

RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

RECRUITING

Cancer Center of Guangzhou Medical University, Guangzhou

RECRUITING

Sun Yai-Sen Memorial Hospital, Sun Yai-Sen University, Guangzhou

RECRUITING

West China Hospital, Sichuan University, Chengdu

RECRUITING

The First Hospital of Lanzhou University, Lanzhou

RECRUITING

Second People's Hospital of Shenzhen, Shenzhen

RECRUITING

The Forth Hospital of Hebei Medical University, Shijiazhuang

RECRUITING

First Hospital of Shanxi Medical University, Taiyuan